Cargando…

The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis

Locally advanced head and neck squamous cell carcinomas (HNSCC) are often refractory to platinum-based radiochemotherapy and new immuno-oncological strategies. To stimulate immunogenic antitumor responses in HNSCC patients, we investigated the cGAS/STING/IFN-1 signaling pathway after genotoxic treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahnreich, Sebastian, El Guerzyfy, Soumia, Kaufmann, Justus, Schmidberger, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573837/
https://www.ncbi.nlm.nih.gov/pubmed/37834346
http://dx.doi.org/10.3390/ijms241914900
_version_ 1785120553700425728
author Zahnreich, Sebastian
El Guerzyfy, Soumia
Kaufmann, Justus
Schmidberger, Heinz
author_facet Zahnreich, Sebastian
El Guerzyfy, Soumia
Kaufmann, Justus
Schmidberger, Heinz
author_sort Zahnreich, Sebastian
collection PubMed
description Locally advanced head and neck squamous cell carcinomas (HNSCC) are often refractory to platinum-based radiochemotherapy and new immuno-oncological strategies. To stimulate immunogenic antitumor responses in HNSCC patients, we investigated the cGAS/STING/IFN-1 signaling pathway after genotoxic treatments and concomitant abrogation of the DNA damage response (DDR). For this purpose, FaDu and UM-SCC1 cells were exposed to X-rays or cisplatin and treated with an ATR or Chk1 inhibitor, or by Fanconi anemia gene A knockout (FANCA ko). We assessed clonogenic survival, cell cycle regulation, micronuclei, free cytosolic double-stranded DNA, and the protein expression and activity of the cGAS/STING/IFN-1 pathway and related players. Cell survival, regulation of G2/M arrest, and formation of rupture-prone cGAS-positive micronuclei after genotoxic treatments were most affected by ATR inhibition and FANCA ko. In UM-SCC-1 cells only, 8 Gy X-rays promoted IFN-1 expression unaltered by abrogation of the DDR or concomitant increased TREX1 expression. At a higher dose of 20 Gy, this effect was observed only for concurrent Chk1- or ATR-inhibition. FANCA ko or cisplatin treatment was ineffective in this regard. Our observations open new perspectives for the enhancement of cGAS/STING/IFN-1-mediated antitumor immune response in HNSCC by hypofractionated or stereotactic radiotherapy concepts in multimodal settings with immuno-oncological strategies.
format Online
Article
Text
id pubmed-10573837
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105738372023-10-14 The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis Zahnreich, Sebastian El Guerzyfy, Soumia Kaufmann, Justus Schmidberger, Heinz Int J Mol Sci Article Locally advanced head and neck squamous cell carcinomas (HNSCC) are often refractory to platinum-based radiochemotherapy and new immuno-oncological strategies. To stimulate immunogenic antitumor responses in HNSCC patients, we investigated the cGAS/STING/IFN-1 signaling pathway after genotoxic treatments and concomitant abrogation of the DNA damage response (DDR). For this purpose, FaDu and UM-SCC1 cells were exposed to X-rays or cisplatin and treated with an ATR or Chk1 inhibitor, or by Fanconi anemia gene A knockout (FANCA ko). We assessed clonogenic survival, cell cycle regulation, micronuclei, free cytosolic double-stranded DNA, and the protein expression and activity of the cGAS/STING/IFN-1 pathway and related players. Cell survival, regulation of G2/M arrest, and formation of rupture-prone cGAS-positive micronuclei after genotoxic treatments were most affected by ATR inhibition and FANCA ko. In UM-SCC-1 cells only, 8 Gy X-rays promoted IFN-1 expression unaltered by abrogation of the DDR or concomitant increased TREX1 expression. At a higher dose of 20 Gy, this effect was observed only for concurrent Chk1- or ATR-inhibition. FANCA ko or cisplatin treatment was ineffective in this regard. Our observations open new perspectives for the enhancement of cGAS/STING/IFN-1-mediated antitumor immune response in HNSCC by hypofractionated or stereotactic radiotherapy concepts in multimodal settings with immuno-oncological strategies. MDPI 2023-10-04 /pmc/articles/PMC10573837/ /pubmed/37834346 http://dx.doi.org/10.3390/ijms241914900 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zahnreich, Sebastian
El Guerzyfy, Soumia
Kaufmann, Justus
Schmidberger, Heinz
The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
title The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
title_full The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
title_fullStr The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
title_full_unstemmed The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
title_short The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
title_sort cgas/sting/ifn-1 response in squamous head and neck cancer cells after genotoxic challenges and abrogation of the atr-chk1 and fanconi anemia axis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573837/
https://www.ncbi.nlm.nih.gov/pubmed/37834346
http://dx.doi.org/10.3390/ijms241914900
work_keys_str_mv AT zahnreichsebastian thecgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT elguerzyfysoumia thecgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT kaufmannjustus thecgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT schmidbergerheinz thecgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT zahnreichsebastian cgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT elguerzyfysoumia cgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT kaufmannjustus cgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis
AT schmidbergerheinz cgasstingifn1responseinsquamousheadandneckcancercellsaftergenotoxicchallengesandabrogationoftheatrchk1andfanconianemiaaxis